Synapse - Works

Results (5712)

(177)Lu-Dotatate plus long-acting octreotide versus high-dose long-acting octreotide in patients with midgut neuroendocrine tumours (NETTER-1): Final overall survival and long-term safety results from an open-label, randomised, controlled, phase 3 trial

Journal Article

Strosberg, J. R.; Caplin, M. E.; Kunz, P. L.; Ruszniewski, P. B.; Bodei, L.; Hendifar, A.; Mittra, E.; Wolin, E. M.; Yao, J. C.; Pavel, M. E.; more...
Lancet Oncology (2021)

Fulltext@MSK | Save

Long-term outcomes of patients with active melanoma brain metastases treated with combination nivolumab plus ipilimumab (CheckMate 204): Final results of an open-label, multicentre, phase 2 study

Journal Article

Tawbi, H. A.; Forsyth, P. A.; Hodi, F. S.; Algazi, A. P.; Hamid, O.; Lao, C. D.; Moschos, S. J.; Atkins, M. B.; Lewis, K.; Postow, M. A.; more...
Lancet Oncology (2021)

Fulltext@MSK | Save

A prospective prostate cancer screening programme for men with pathogenic variants in mismatch repair genes (IMPACT): Initial results from an international prospective study

Journal Article

Bancroft, E. K.; Page, E. C.; Brook, M. N.; Thomas, S.; Taylor, N.; Pope, J.; McHugh, J.; Jones, A. B.; Karlsson, Q.; Merson, S.; more...
Lancet Oncology (2021)

Fulltext@MSK | Save

Apalutamide plus abiraterone acetate and prednisone versus placebo plus abiraterone and prednisone in metastatic, castration-resistant prostate cancer (ACIS): A randomised, placebo-controlled, double-blind, multinational, phase 3 study

Journal Article

Saad, F.; Efstathiou, E.; Attard, G.; Flaig, T. W.; Franke, F.; Goodman, O. B. Jr; Oudard, S.; Steuber, T.; Suzuki, H.; Wu, D.; more...
Lancet Oncology (2021)

Fulltext@MSK | Save

Global guideline for the diagnosis and management of the endemic mycoses: An initiative of the European Confederation of Medical Mycology in cooperation with the International Society for Human and Animal Mycology